Clinical Site

Amsterdam 1105AZ

0 studies enrolling now · 4 studies all time

What they study most

C3 Glomerulopathy (C3G), Cardiovascular Disease, Celiac Disease, Elevated Lipoprotein(a), In-situ Small Bowel T-cell Lymphoma, Type II Refractory Celiac Disease (RCD-II)

Studies at this site

• PRV-015 in Gluten-free Diet Non-responsive Celiac Disease — Completed
• Controlled Trial Evaluating Avacopan in C3 Glomerulopathy — Completed
• Phase 2 Study of ISIS 681257 (AKCEA-APO(a)-LRx) in Participants With Hyperlipoproteinemia(a) and Cardiovascular Disease — Completed
• Study to Evaluate the Efficacy and Safety of AMG 714 in Adult Patients With Type II Refractory Celiac Disease — Completed